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Abstract
Toll-like receptor signaling requires functional Toll/interleukin-1 (IL-1) receptor (TIR) domains to activate innate immunity. By
producing TIR homologous proteins, microbes inhibit host response induction and improve their own survival. The TIR
homologous protein TcpC was recently identified as a virulence factor in uropathogenic Escherichia coli (E. coli), suppressing
innate immunity by binding to MyD88. This study examined how the host MyD88 genotype modifies the in vivo effects of
TcpC and whether additional, TIR-domain containing proteins might be targeted by TcpC. In wild type mice (wt), TcpC
enhanced bacterial virulence, increased acute mortality, bacterial persistence and tissue damage after infection with E. coli
CFT073 (TcpC+), compared to a DTcpC deletion mutant. These effects were attenuated in Myd88
2/2 and Tlr4
2/2 mice.
Transcriptomic analysis confirmed that TcpC inhibits MYD88 dependent gene expression in CFT073 infected human
uroepithelial cells but in addition the inhibitory effect included targets in the TRIF and IL-6/IL-1 signaling pathways, where
MYD88 dependent and independent signaling may converge. The effects of TcpC on bacterial persistence were attenuated
in Trif
2/2 or Il-1b
2/2 mice and innate immune responses to DTcpC were increased, confirming that Trif and Il-1b dependent
targets might be involved in vivo, in addition to Myd88. Furthermore, soluble TcpC inhibited Myd88 and Trif dependent TLR
signaling in murine macrophages. Our results suggest that TcpC may promote UTI-associated pathology broadly, through
inhibition of TIR domain signaling and downstream pathways. Dysregulation of the host response by microbial TcpC thus
appears to impair the protective effects of innate immunity, while promoting inflammation and tissue damage.
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Introduction
Toll-like receptors (TLRs) control innate host responses to
mucosal and systemic infections and signaling involves the
intracellular Toll/interleukin-1 receptor (TIR) domain [1].
Following ligand binding, signaling is initiated by the recruitment
of adaptor proteins to the TIR domain [2,3,4], including myeloid
differentiation factor-88 (MYD88), MYD88 adapter-like protein
(Mal), TIR domain-containing adaptor protein inducing IFNb
(TRIF), TRIF-related adaptor molecule (TRAM) and the sterile a-
and armadillo-motif-containing protein (SARM). Negative regu-
lators of TLR signaling include SIGIRR, MyD88s and IRAK-M,
which block MyD88 dependent activation, or Triad3A and
SARM, which block the TRIF dependent pathway. The SIGIRR
TIR domain resembles MyD88 but lacks two amino acids needed
for signaling to occur [5,6]. However, TIR-TIR interactions
between SIGIRR and TLR4 prevent the recruitment of IRAK
and TRAF6 to MyD88 [6]. MyD88s is a splice variant inhibiting
MyD88 dependent TLR4 activation by allowing MyD88 to bind
the intermediate IRAK-binding domain without inducing IRAK
phosphorylation and NF-kB activation [7]. IRAK-M prevents
IRAK and IRAK-4 dissociation from MyD88 and TRAF6
complex formation [8]; Triad3A interacts with TIR domains of
TLRs, TRIF, TIRAP and RIP1 [9]; and SARM blocks gene
induction downstream of TRIF [10]. Competition at the level of
the TIR domain is thus used by host cells to modify TLR signaling
in response to specific agonists [6,7,11,12].
Pathogens have also evolved mechanisms to inhibit the TLR
dependent host defense and to increase their fitness and virulence
for a specific host niche [12]. The TIR domain plays a crucial role
in the mammalian innate immune response and recently proteins
containing TIR domains have been described in a wide variety of
bacteria, fungi, archaea and viruses [13]. Whole genome
sequencing and structural studies have revealed that several
pathogens carry TIR-domain homologous sequences, including
two proteins from Vaccinia virus A46R and A52R, which interfere
with IL-1 and TLR4 mediated activation of NF-kB [14]. Similar
proteins were identified in Salmonella, Brucella and uropathogenic
E. coli (UPEC) [12,15,16]. On the other hand, Spear and
co-workers suggested that most TIR domains in bacteria did not
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function as general purpose protein-protein interaction domains
for diverse uses [13]. We recently showed that the TIR
homologous protein TcpC in the UPEC strain E. coli CFT073
acts as a virulence factor by suppressing innate host responses in
the kidney, enhancing bacterial persistence and tissue damage
[12]. Epidemiologic studies of patient E. coli isolates showed that
TcpC occurred more frequently in strains causing severe kidney
infections than in E. coli causing other forms of urinary tract
infection (UTI) [12]. The UTI model is therefore quite suitable to
investigate the mechanisms of TcpC-modulation of the innate host
response in vivo and the consequences for bacterial persistence and
disease severity [11].
TcpC binds to MyD88 [12] but it remains unknown if other
TIR-domain containing molecules of the host are influenced by
TcpC in vivo. This study addressed this question with the aim to
define the genetic control of TcpC mediated immune inhibition in
vivo. We used the murine UTI model and mice lacking specific
innate immune response genes to examine whether Myd88
controls the TcpC dependent response to UPEC infection and if
additional Myd88 independent signaling pathways might modify
the effects of TcpC in vivo. Furthermore, transcriptomic and
proteomic analysis of infected human epithelial cells was used to
define targets of TcpC and effects on innate immune activation by
UPEC and inhibition of TLR signaling by soluble TcpC protein
was defined in murine macrophages. The results suggest that
TcpC partially inhibits TIR domain dependent signaling in vivo
and in host cells including pathways downstream of MYD88,
where MYD88 dependent and independent innate immune
responses may converge. In this way, broad but incomplete
suppression by microbial TcpC, may impair innate immune
protection, while promoting inflammation and tissue damage.
Results
TcpC increases bacterial burden, abscess formation and
tissue pathology
Experimental UTI was established in wild type (wt) C57BL/6
mice by intravesical infection with E. coli CFT073 (CFT073) or the
CFT073tcpC::kan mutant (DTcpC) [12] and was monitored for
seven days. A higher bacterial burden was present after CFT073
infection compared to DTcpC (p,0.001, Figure 1B) in urine
samples obtained daily after infection. This difference was
reproduced in kidneys (p,0.001) obtained on days four or seven
after infection (Figure 1A). MIP-2 chemokine concentrations and
neutrophil responses in urine were higher in mice infected with
CFT073 compared to DTcpC (p,0.001; Figure 1C, D). Tissue
damage was extensive in mice infected with CFT073; the kidneys
were large, pale and soft and abscesses were present in 75% of the
organs (Figure 1E, F). In contrast, kidneys of mice infected with
DTcpC were normal in size, color and texture and lacked
detectable abscesses (p,0.05, Figure 1E, F).
The host Tlr4 and Myd88 genotypes control CFT073 and
DTcpC infection and renal pathology
Experimental UTI with CFT073 or the DTcpC mutant was
subsequently established in Tlr4 and Myd88 adaptor protein
knockout mice in the C57BL/6 background (Tlr4
2/2 and
Myd88
2/2 respectively). Total bacterial counts and the TcpC
dependent difference in bacterial persistence were reduced in the
mutant mice, compared to wt mice (Figure 1). Bacterial counts in
urine were lower in Myd88
2/2 (p,0.05) and Tlr4
2/2 (p,0.05)
mice as compared to wt mice (Figure 1). In addition, the renal
bacterial counts were significantly lower in mutant mice on day
seven than in wt animals which were infected with CFT073
(p,0.05, Figure 1A). However, there was no difference in bacterial
counts in wt and mutant mice which were infected with DTcpC
(Figure 1A). The MIP-2 and neutrophil responses were absent in
infected Myd88
2/2 mice and drastically reduced in Tlr4
2/2
compared to C57BL/6 wt mice (p,0.0001, Figure 1C, D),
confirming that these aspects of the early innate immune response
require Myd88 and Tlr4 dependent signaling. Kidneys of Tlr4
2/2
and Myd88
2/2 mice infected with CFT073 or the DTcpC mutant
were normal in size, color and texture and had no abscesses
(Figure 1E, F).
TcpC-related differences in bacterial persistence were observed
also in the mutant mice (Figure 1). Tlr4
2/2 and Myd88
2/2 mice
developed significant bacteriuria ($10
5 CFU/ml of urine) six
hours after infection with CFT073 or DTcpC and bacteria persisted
in urine until the experimental end point. Higher numbers of
CFT073 than DTcpC were observed on day one in Tlr4
2/2 mice
(p,0.01); and on days one, four and six in Myd88
2/2 mice
(p,0.01, Figure 1B). In addition, CFT073 numbers were higher
than DTcpC in kidneys of Myd88
2/2 and Tlr4
2/2 mice (p,0.01)
on days four and seven (Figure 1A). The difference between
CFT073 and DTcpC was reduced compared to wt mice in Tlr4
2/2
(p,0.01) and Myd88
2/2 mice (p,0.01) by more than two logs in
urine (Figure 1A). TcpC dependent increases in MIP-2 and
neutrophil responses observed in wt mice were lost in Tlr4
2/2
mice, the, confirming the essential role of TLR4 and its TIR
domain for innate immune responses to UTI (Figure 1C and D).
The Myd88
2/2 mice did not mount MIP-2 and neutrophil
responses to CFT073 or DTcpC infection. These results suggest
that TcpC affects bacterial persistence and pathology, in part, via
Tlr4 and Myd88 dependent but also via Myd88 independent
pathways.
Author Summary
The clinical manifestations of infection range from
beneficial, asymptomatic states to life threatening disease,
depending on the arsenal of virulence factors carried by
the bacteria and the host immune defence repertoire.
Pathogenic bacteria have evolved many sophisticated
ways of avoiding the host defence and especially the
immune response to infection. In this study, we present a
very interesting case where bacteria actively inhibit the
immune response by producing a host defence like
protein, TcpC, which acts by promoting bacterial survival
and corrupting the tissue response to infection such that
the tissues are damaged rather than protected. The
importance of TcpC is demonstrated in a mouse model
of urinary tract infection (UTI) and in isolated human and
murine kidney cells. The results suggest that TcpC
expressing bacteria cause death, inflammation and tissue
damage in normal hosts by creating a dysfunctional innate
immune response and that partial inhibition of adaptor
proteins turns the normally protective defense into lethal
inflammation, followed by kidney tissue damage. In
human cells, TcpC was a broad innate immune inhibitor,
acting via the MYD88, TRIF and IL-1/IL-6 pathways. Our
report increases the understanding of how TcpC and
microbial proteins with similar targets succeed in shifting
the balance in favor of the pathogen, thus promoting
disease. These data are fundamentally important in
showing pathways for host defense that can be fine tuned
by a bacterial virulence factor in order to paradoxically
promote bacterial replication thereby illustrating the host
response as a generator of pathology.
Escherichia coli TIR-Proteins
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mice
Kidney sections from CFT073 infected wt mice (htx-eosin, day
7) showed swollen collecting ducts and inflammatory cell infiltrates
into the kidney parenchyma (Figure 2A). P-fimbriated bacteria
were present in the tissues, from the pelvic region to the cortex, as
shown by PapG specific antibody staining. Neutrophils were
abundant in the abscesses and scattered throughout the tissue, as
shown by a neutrophil specific antibody (areas AI-AIII in
Figure 2A). By dual staining, P fimbriae and neutrophils were
detected in the abscesses and collecting ducts (Figure 2A). In
contrast, kidney sections from mice infected with DTcpC showed
normal structure, no bacteria and few inflammatory cells (areas
BI-BII in Figure 2B). Figure 2C shows htx-eosin stained sections
from an uninfected control kidney and the inset shows a negative
control section stained with the anti-neutrophil and anti-PapG
antibodies. The results suggest that TcpC reduces host resistance
and increases inflammation, resulting in a high bacterial burden
and tissue damage as these sequels become attenuated in mice
infected with the DTcpC mutant.
Htx-eosin stained sections from Myd88
2/2 and Tlr4
2/2 mice
infected with CFT073 showed normal collecting ducts, few
inflammatory cells and no bacteria in the medulla or cortex of
kidneys from either host (Figure 3A). P fimbriae or neutrophils
were not detected in infected kidneys by immunohistochemistry
(Figure 3B). Similarly, there was no tissue pathology in Myd88
2/2
and Tlr4
2/2 mice infected with the DTcpC mutant. The results
suggest that a host response involving Tlr4 and Myd88 leads to
TcpC dependent kidney pathology after CFT073 infection and
that hosts lacking Tlr4 or the adaptor are protected from such
tissue damage.
Transcriptomic analysis of host responses to CFT073 and
DTcpC in human uroepithelial cells
While the in vivo experiments confirmed that TcpC mediated
virulence depends on pathways controlled by Myd88, they also
suggested that TcpC modifies additional host response pathways.
To identify such pathways, human A498 kidney epithelial cells
wereinfected invitrowith CFT073orDTcpC(4 hours,10
8 CFU/ml)
and complementary RNA was hybridized to Illumina whole
genome microarrays. A heat map of significantly regulated
genes is shown in Figure 4A (means of triplicate spots). In
identification of CFT073 or DTcpC-specific genes, fold changes
of $2 were used. For the comparison of CFT073 or DTcpC, a
fold change in response to either strain .1.5 relative to the
respective control was used.
Infection stimulated marked changes in gene expression and
three major groups of genes were altered; 734 regulated genes
were shared, 21 genes responded only to CFT073, while 11
responded only to DTcpC (Figure 4B, Supplementary Table S1).
Differentially expressed genes between unstimulated and CFT073
or DTcpC treated cells were then characterized using Ingenuity
Pathway Analysis. Notably, signaling downstream of pattern
recognition receptors, interferon induction, interferon response
and IL-6/IL-1 signaling pathways were among the top-scoring
pathways identified (Figure 4C). To further study the mechanisms
of TcpC mediated innate immune inhibition, differentially
transcribed genes were assigned to known response pathways
(Figure 5, Supplementary Table S1). Consistent with the proposed
role of TcpC as a MYD88 inhibitor [12], in vitro infection with
DTcpC upregulated MYD88 dependent transcripts involved in
pathogen pattern recognition, compared to CFT073 infected cells
(p.0.01). These include the inflammatory cytokines IL-6, IL-8,
TNF-a, IL-1a/b and the transcription factors IRF7 and NF-kB1,
2 (Figure 5A, Green). In addition, the expression of downstream
pro-inflammatory genes including IL-1a/b, TNFAIP6 and
TNFRSF11b were upregulated in DTcpC compared to CFT073
infected cells (Figure 5B, Green), while the transcription of
negative regulators IL-1RA, NFkBIa and NFkBIb was reduced,
consistent with activation of the MYD88 pathway (Figure 5B,
Red). Interestingly, a corresponding reduction in the MAP kinase
MAP2K3, JUN and FOS transcripts was observed, suggesting a
partial rather than complete suppression of the MYD88 pathway
by TcpC (Figure 5B, Red). NF-kB and IRF7 transcript levels,
which are both MYD88 and TRIF dependent, were significantly
increased after DTcpC infection compared to CFT073 (p,0.01),
suggesting that also TRIF-dependent signaling, might be inhibited
by TcpC. Other genes downstream of TRIF maintained their
activity regardless of TcpC, however.
In order to validate the transcriptomic analysis, expression levels
of selected genes were confirmed by RT-PCR in the cells infected
with CFT073 or DTcpC (Figure 6A). Significant differences were
observed for IL-8, IL-6, NFkB1, TNF- a and c-FOS. The pattern
reflected a trend similar to that revealed by microarray analysis for
the gene products tested (Figure 5B*, Red).
To generate further insights into the effects of TcpC, cultured
human kidney cells were stimulated with either CFT073 or DTcpC
and culture medium was assayed using the Procarta human
cytokine kit (Figure 6B). DTcpC stimulation resulted in significantly
elevated levels of MYD88 dependent proinflammatory cytokines
(IL-6, IL-8, TNF-a)( p ,0.01) compared to the wild type strain,
corroborating the transcriptomic analysis and suggesting that
MyD88 and TRIF dependent pathways are modified by TcpC. In
addition, DTcpC stimulation resulted in increased expression of the
neutrophil chemoattractants MCP-1, GRO-a and MIP-3a
(Figure 6B), while in vivo infection with DTcpC caused a lower
MIP-2 response than CFT073.
The apparent discrepancies between the in vivo data and in vitro
results were further examined, by establishing murine tubular
kidney cell lines from wt and Myd88
2/2 or Trif
Lps2/Lps2 mutant
mice. The cells were infected with CFT073 or DTcpC and MIP-2
secretion was quantified by ELISA, four hours after infection
(Supplementary Figure S1). MIP-2 secretion was reduced in
DTcpC infected compared to CFT073 infected cells from wt mice,
consistent with the increased response to CFT073 in wt mice. In
Trif
Lps2/Lps2 cells, MIP-2 secretion was also reduced in DTcpC
compared to CFT073 infected cells (Supplementary Figure S1).
Furthermore, the in vitro response of cells from Myd88
2/2 mice
was very low, both to CFT073 and DTcpC, thus reproducing the
lack of response in mutant mice. By RT-PCR, the MIP-2 response
to DTcpC was reduced compared to CFT073 in cells from wt mice
Figure 1. TcpC acts as a virulence factor by promoting bacterial persistence in the urinary tract and abscess formation in the
kidneys of wild type mice. (A) Bacterial counts (CFUs) in kidneys of C57BL/6, Tlr4
2/2 and Myd88
2/2 on days 4 and 7 post-infection. (B) Bacterial
counts (CFUs) in urine of C57BL/6, Tlr4
2/2 and Myd88
2/2 mice after infection with CFT073 or DTcpC. (C) MIP-2 response kinetics in urine samples of
wt and mutant mice. (D) Neutrophil response kinetics in urine samples of wt and mutant mice. P values (*p,0.05, **p,0.01 and ***p,0.001 for
CFT073 versus DTcpC mutant and for wt versus mutant mice; Fisher’s exact test). Eight to ten mice were used per time point. (E) Abscess formation
(arrows) in the kidneys of wt mice infected with CFT073 but not in Tlr4
2/2 and Myd88
2/2 mice infected with CFT073 or DTcpC (Scale bar, 2 mm).
(F) Abscess formation after CFT073 or DTcpC infection, in percent of the total number of kidneys examined.
doi:10.1371/journal.ppat.1001120.g001
Escherichia coli TIR-Proteins
PLoS Pathogens | www.plospathogens.org 4 September 2010 | Volume 6 | Issue 9 | e1001120Figure 2. Deletion of TcpC abrogates abscess formation in kidney sections from wild type mice infected with CFT073. (A) Overview of
htx-eosin stained kidney section of wt mice infected with CFT073, showing abscesses (scale bar, 500 mm). Magnified areas of section A shown as A-I,
A-II and A-III are stained with specific antibodies to neutrophils (green, NIMP-R14) and the PapG adhesin (red, antiserum to a synthetic PapG peptide)
(scale bar, 100 mm). Abscesses in wt mice are shown by dotted lines. (B) Overview of kidney section of wt mice infected with DTcpC (scale bar,
Escherichia coli TIR-Proteins
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2/2 mice but not different in
cells from Trif
Lps2/Lps2 mice (data not shown), Thus most but not
all of the in vitro results were compatible with the in vivo data, either
in human or murine kidney cells. Differences between in vivo data
and in vitro assays are expected to occur, as the in vivo response of
an entire organ system is unlikely to be reflected by a single cell
type in vitro.
TcpC dependent virulence and innate immune responses
act via the Trif signaling pathway
The cellular studies and findings in Myd88
2/2 and Tlr4
2/2
mice suggested, that bacterial TcpC might inhibit TLR4
dependent signaling, also through the Trif adaptor. To examine
this hypothesis, Trif adaptor protein knockout mice (Trif
2/2) were
infected with CFT073 or the DTcpC mutant and compared to wt
C57BL6/129 mice. The DTcpC mutant established higher
bacterial counts in urine than CFT073 in Trif
2/2 mice
(p,0.001), in contrast to C57BL6/129 wild type mice
(Figure 7B, p,0.001). Furthermore, the difference in kidney
counts between CFT073 and DTcpC in wt mice (Figure 7A,
p,0.001) was not observed in Trif
2/2 mice, indicating that the
effects of TcpC on bacterial persistence are neutralized in mice
with defective Trif signaling. Trif
2/2 mice also exhibited a
significant MIP-2 response to DTcpC compared to CFT073
(p,0.05, day 3 and 6) (Figure 7C) and the neutrophil response
to DTcpC was significantly higher (p,0.001, Figure 7D).
The effects of Trif on TcpC inhibition were confirmed in
Trif
Lps2/Lps2 mice, which carry a non-functional co-dominant Trif
allele, induced by N-ethyl-N-nitrosourea mutagenesis on a pure
C57BL/6 background [17] (Figure 7). As in Trif
2/2 mice, the
DTcpC mutant established higher bacterial counts in urine than
CFT073 in contrast to C57BL/6 wt mice (Figure 7B, p,0.001).
The TcpC related difference in kidney counts between CFT073
and DTcpC in wt mice (Figure 7A, p,0.001) was not observed in
Trif
Lps2/Lps2 mice and the MIP-2 and neutrophil responses to
DTcpC were significantly higher compared to CFT073 (Figure 7C,
D; p,0.01). However, neither CFT073 nor DTcpC induced kidney
abscesses in Trif
2/2 mice or in Trif
Lps2/Lps2 mice (Figure 7E, F).
The results suggest that the Trif adaptor protein is involved in the
innate immune mechanisms controlling the persistence of TcpC
expressing bacteria.
Inhibitory effects of TcpC on TLR signaling in murine
macrophages
To confirm that the TIR domain of TcpC impaired MyD88-
dependent TLR signaling, bone marrow derived macrophages
(BMDMs) from wild type or Myd88
2/2 mice were stimulated with
different TLR ligands in the presence of titrated amounts of TIR-
TcpC, the c-terminal half of TcpC containing the TIR domain.
TIR-TcpC impaired TNF secretion induced by the different TLR
ligands with the exception of TLR3 mediated stimulation, as
expected from the MyD88 independence of TLR3 (Figure 8A) [12].
Also as expected only poly(I:C) and LPS were able to induce TNF
secretion in Myd88
2/2 BMDMs, presumably via Trif. Interestingly,
TIR-TcpC impaired this pathway as well, consistent with the in vivo
observation that the Trif pathway was influenced by TcpC
(Figure 8B). In addition, control experiments showed that TcpC is
secreted into the urine of infected mice (data not shown).
Influence of Il-1b and Irf3 on TcpC dependent virulence
The transcriptomic analysis suggested that TcpC strongly
regulates the pro-inflammatory cytokines IL-6 and IL-1a/b,a s
well as downstream signaling pathways. Enhanced expression of
IL-1a/b (p,0.03 for IL-1a and p,0.02 for IL-1b)i nDTcpC
infected human cells suggested that the inhibitory effect of TcpC
includes IL-1 dependent inflammation. To address this question,
Il-1b
2/2 mice were infected with CFT073 or DTcpC, as described.
The TcpC dependent difference in bacterial persistence and host
response induction was reduced in these mice (p,0.0001, Figure 9).
Renal abscess formation or tissue pathology was not observed.
IRF3 is a transcription factor controlling interferon responses to
viral infection [18]. More recently, the involvement of IRFs in
immunoregulation by TLRs has received more attention, since
NF-kB, IRF3 and AP-1 form transcriptional complexes that
regulate innate immune responses in monocytes [19]. We have
recently identified IRF3 as an essential transcription factor in UTI,
acting downstream of TLR4/TRAM (unpublished observation).
To examine if Irf3 might be involved in TcpC mediated innate
immune suppression, infection with CFT073 or DTcpC was
established in Irf3 mutant mice (Irf3
2/2), using wt C57BL/6
mice as controls. The difference in persistence between CFT073
and DTcpC in wild type mice was not observed during the early
phase of infection in Irf3
2/2 mice (,day 5) (Figure 9A, B).
Furthermore, in Irf3
2/2 mice, the early chemokine and neutrophil
responses were delayed compared to responses in wt controls
(Figure 9C, D). Significantly reduced responses to DTcpC were
only observed from day five post-infection in Irf3
2/2 mice
(Figure 9C, D), showing that the response kinetics differed from
wt mice. Abscess formation in response to CFT073 was as frequent
in the Irf3
2/2 as in wt mice (Figure 9E, F). The results suggest that
the effect of TcpC on bacterial persistence and on the MIP-2
response are attenuated during the early phase of infection in
IRF3-deficient mice and that IRF3 signaling is differentially
activated depending on the TcpC status of the infecting strain
(Please see figure 9B–D).
Taken together, the results show that bacterial TcpC modifies
the innate host response broadly through inhibition of Tlr4,
Myd88, Trif, IL-6/IL-1 and Irf3 dependent antibacterial effector
functions.
Discussion
Bacterial TIR-like proteins are important virulence factors,
which act by inhibiting innate immunity, thus facilitating the
survival and persistence of several pathogens. The Salmonella
enteritica TlpA protein enhances bacterial survival in macrophages
and mice [15] and the Brucella TcpB protein inhibits TIRAP
mediated signaling and reduces systemic spread of bacteria during
the early stages of infection [16]. The E. coli TcpC protein
increases virulence in the urinary tract and we have previously
proposed that TLR signaling is impeded through the MYD88
adaptor via direct binding of TcpC to MYD88 [12]. This study
addressed the mechanism through which TcpC modifies the
innate immune response in the infected host, by varying the innate
immune genetic repertoire. The results show that TcpC requires
Myd88 to act as a virulence factor in vivo. Transcriptomic analysis
identified additional targets for TcpC in human cells, including the
TRIF and IL-6 pathways, as well as IL-1a/b. Tlr4
2/2, Trif
2/2,
300 mm). Magnified areas of section B shown as areas B-I and B-II are stained with specific antibodies as described above. (C) Kidney section of
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2/2 and adaptor protein mutant mice infected with CFT073 andDTcpC. (A) Overview
of htx-eosin stained kidney section of Tlr4
2/2, Myd88
2/2 and Trif
2/2 mice. Scale bar, 500 mm. (B) Histology of renal cortex stained with specific
antibodies to neutrophils (green, NIMP-R14) or the PapG adhesion (red, antiserum to a synthetic PapG peptide). Scale bar, 100 mm. Neutrophils or
bacteria were not detected in the tissues. The Tlr4
2/2 and Myd88
2/2 mice were compared to C57BL/6 wt mice andTrif
2/2 mice to C57BL6/129 wt mice.
doi:10.1371/journal.ppat.1001120.g003
Escherichia coli TIR-Proteins
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2/2 and Il-1b
2/2 mice exhibited markedly different immune
responses to TcpC stimulation and the TcpC dependent change in
bacterial persistence and pathology was attenuated in these mice.
The results thus suggest that pathways for host-defense can be fine-
tuned by a bacterial virulence factor in order to paradoxically
promote bacterial replication and pathology.
Figure 4. Uroepithelial gene expression in response to in vitro infection with CFT073 or DTcpC. (A) A two-dimensional hierarchical heat
map illustrating differentially transcribed genes in human A498 cells infected with CFT073 or DTcpC versus the control group. Analysis was performed
on 766 genes with a fold change of at least two over untreated cells, and classified based on whether they are CFT073 or DTcpC specific, or common
to both infections. Induced genes are represented by brighter shades of red, while down regulated genes are represented by brighter shades of
green (see color scale). (B) Venn diagram showing numerical distribution of differentially expressed genes in CFT073 (red) and DTcpC infected (blue)
cells compared to mock infected cells. (C) A comparison of the 10 highest scoring biological pathways between infected cells and controls as
analyzed by Ingenuity Pathway Analysis with default settings.
doi:10.1371/journal.ppat.1001120.g004
Figure 5. Identification of pathway-specific genes by Ingenuity Pathway Analysis in response to in vitro infection. (A-I) Pattern
recognition pathway. (A-II) IL-6/IL-1 pathway. Each node represents a protein whose functional class is represented by various shapes
(ovals=transcription factors, spiral=kinases, dumbbell=transcription regulators, V shape=cytokine or growth factors, Y shape=transmembrane
receptors, circles=others). Direct protein interactions are represented by solid lines, while dashed lines indicate indirect interaction. A red node
indicates up regulation of a protein in response to CFT073, while a green node indicates down regulation by CFT073 relative to DTcpC.
doi:10.1371/journal.ppat.1001120.g005
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by the TLRs as well as the interleukin-1 receptor [20,21]. By
targeting MyD88, TcpC would thus be expected to impair both
TLR- and IL-1 dependent signaling pathways as well as related
antibacterial effector functions. This interpretation was supported
by the in vivo effects, which were not restricted to Myd88 but
regulated by a group of genes encoding proteins with a TIR
domain or regulated by such proteins. In Myd88
2/2 mice,
essential chemokine and neutrophil responses to CFT073 infection
were completely abrogated consistent with the importance of
MyD88 for the overall innate immune response to these infections.
The response to infection was strongly reduced also in Tlr4
2/2
mice confirming our previous findings that Tlr4 signaling is
essential for the innate immune response to UTI and suggesting
that that inhibition of TLR4 responses may be protective at the
mucosal level [11,22,23,24]. We have recently extended the
analysis of potential eukaryotic interaction partners and have
shown that the TIR-domain of TcpC binds to TLR4 in addition to
MyD88 (unpublished observation). TcpC did not bind to TRIF or
TLR2, however [12]. Thus, as expected by the differing
aminoacid sequences, only selected TIR-domains bind TcpC.
The difference in bacterial persistence, while reduced, was not
abrogated in Tlr4
2/2 or MyD88
2/2 mice, however, possibly
reflecting the involvement of pathways that remains intact in
Myd88
2/2 mice. The interaction with TLR4 provides a molecular
basis for inhibition of the TRIF-dependent arm of the TLR4
signaling cascade, thus possibly explaining, in part, the effects of
TcpC in Trif
2/2 mice.
This mode of action of TcpC was also supported by the
experiments in murine macrophages, where responses to most of
the TLR specific ligands were inhibited by purified TcpC-TIR
protein. TcpC inhibited LPS-driven, MyD88 dependent and LPS-
driven MyD88-independent TNF secretion, including TLR4-
TRIF signaling. However, TcpC did not influence poly (I:C)-
induced TNF-secretion, whether MyD88 dependent or not. The
fact that poly (I:C)-induced TNF-secretion in the absence of TcpC
was lower in MyD88-deficient cells compared to wild type cells
cannot be interpreted to imply that poly (I:C) stimulates MyD88-
dependent TNF-secretion, since resting MyD88-deficient macro-
phages are impaired in their basal expression of several cytokines
including TNF [25]. Cytokines like TNF are in general harder to
induce in MyD88-deficient cells, as also reported by Sun et al.
[26]. In preliminary experiments, we have also analyzed the
secretion of the chemokine KC and have not found differences in
wild type or MyD88-deficient cells after stimulation with poly
(I:C). Thus, poly (I:C) stimulates cells in a MyD88-independent
but TRIF-dependent manner and the results are compatible with
the in vivo effect.
TRIF has a well conserved TIR domain and several TRAF6
binding regions within the N- and C-terminal RIP homotypic
interaction motifs (RHIM) [27,28,29]. TRAM is TLR4 specific
[30,31] and the myristoylated N-terminus associates to the plasma
membrane and protein kinase Ce phosphorylation of Serine 6 and
16 is essential for TRAM activation [32,33]. In contrast to
MYD88, TRIF dependent signaling activates both NF-kB and
IRF3/7 [30]. After TRAM dependent TLR4 activation, TRIF
forms a complex with TRAF3, IRAK1 and an IKK-like kinase.
TRAF family member associated NF-kB activator (TANK)-
binding kinase 1 (TBK1) and the IKK homolog, IKKe, phos-
phorylate IRF3 at its C terminus [30,34], initiating IFN-a/b
transcription [29]. IRF7 becomes activated in a similar manner
[4]. In this study, TcpC suppressed transcription of NF-kB and
IRF7 as well as IL-8, TNF-a, IL-1a/b and IL-6, which is
consistent with the effects on MYD88 and possibly TRIF. The in
vivo response to infection supports the conclusion that TcpC also
suppresses Trif dependent effector functions, however, as Trif
2/2
mice have a functional Myd88 response, except for the
cooperative TLR4 response to LPS [35]. The lack of pathology
in infected Trif
2/2 mice further suggests that Trif signaling is
essential for efficient innate immune-mediated clearance of UPEC
infection.
The transcriptomic analysis of infected human kidney cells
suggested that TcpC also modifies proinflammatory cytokine
signaling downstream of MYD88 and TRIF. The IL-6 pathway
was strongly regulated and IL-1a/b expression was reduced by
TcpC. The involvement of IL-1 was confirmed by infection of
Il-1b
2/2 mice and the phenotype of the Il-1b
2/2 mice was quite
convincing, as the difference in bacterial persistence between
CFT073 and the TcpC deficient mutant in wt mice was abrogated
in Il-1b
2/2 mice and the innate immune response to the two
isogenic strains was similar. Bacterial clearance was rapid, further
suggesting that IL-1 may be a significant factor in the mucosal
response to UPEC and in the establishment of tissue pathology.
The mechanism of TcpC modulation of IL-1 is not clear, however
and may either relate to a TIR domain dependent interaction of
TcpC with the IL-1 receptor, effects on upstream signaling
involving Myd88 and Trif and the resulting IL-1 response or to
other mechanisms.
Recently, Trif dependent innate immune responses have been
shown to activate IRFs that regulate the transcription of pro-
inflammatory genes, including IL-8, IL-6 and TNF, in addition to
interferon genes [18]. In a parallel study, we have characterized a
new TLR4/TRAM dependent pathway that mediates innate
responses to P-fimbriated, uropathogenic E. coli through Irf3
(unpublished observation). Using a combination of transcrip-
tomics, phosphorylation arrays and imaging technology, we
detected TRAM phosphorylation, activation of MAP kinases
including p38, CREB phosphorylation and nuclear IRF3
translocation. Irf3
2/2 mice lacking this pathway, developed rapid
lethal kidney infections with extensive tissue damage and patients
prone to acute pyelonephritis were shown to carry IRF3 promoter
polymorphisms that reduce transcription efficiency. In the present
study, interferon dependent pathways were differentially regulated
by TcpC in vitro (data not shown) and in Irf3
2/2 mice the effects of
TcpC were significantly delayed compared to wt mice. While this
effect was transcient, the results further support the results
suggesting that TcpC may modify the effects of the TRIF/Irf3
pathway and the progression to disease and pathology.
Innate immune activation by uropathogenic E. coli is orches-
trated by specific virulence factors and essential aspects of the
mucosal response show pathogen specificity [36]. Such interac-
tions are needed, as innate immune responses are not activated by
asymptomatic carrier strains in the epithelial tissue, which forms a
barrier against interactions with inflammatory cells, with broader
Figure 6. Protein array analysis in response to in vitro infection with CFT073 or DTcpC. (A) RT-PCR analysis of human kidney cell lines
infected with CFT073 or DTcpC for 4 hrs. All values represent means 6 SEMs of three experiments. (B) Uroepithelial cytokine responses to infection
with CFT073, DTcpC or mock-infected controls. A498 cells were stimulated for 4 hours with the indicated bacterial strains. Supernatant cytokine levels
are in pg/ml and represent means 6 SEMs of three experiments. Significant differences are indicated by single * (p,0.05), double ** (p,0.01) or
triple asterisks *** (p,0.001, Student’s t-test).
doi:10.1371/journal.ppat.1001120.g006
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CD14 and do not respond to conserved bacterial PAMPS like LPS
[11,36]. In addition, asymptomatic carrier strains may actively
suppress the mucosal immune response, but the mechanisms are
not fully understood. We have previously shown that pathogen
specific TLR4 activation favours TRIF or MyD88, depending on
the surface fimbriae, which are expressed in a pathogen specific
manner and serve as crucial virulence factors involved in
attachment and host tissue perturbation [11]. P fimbriated
bacteria preferentially activate TLR4/TRIF signalling while Type
1 fimbriae trigger TLR4 responses mainly involving MyD88. The
adaptor protein usage in infected host cells can even be shifted
from TRIF to MyD88 by a change in fimbrial expression [11].
E. coli CFT073, used in the present study, expresses both P and
type 1 fimbriae, thus activating TLR4 signalling involving TRIF
and MyD88 responses in infected cells, providing a basis for
independent targeting of these pathways by TcpC.
In conclusion, our results suggest that TcpC may act as a broad
microbial innate immune response modulator in vivo,b y
preventing bacterial clearance and dysregulating inflammation,
with destructive effects on infected tissues. This adds TcpC to an
increasing number of components that regulate TLR and MYD88
Figure 7. Effects of TcpC virulence in Trif
2/2 and Trif
Lps2/Lps2 mice infected with CFT073 or DTcpC. (A) Bacterial burden (CFU) in kidneys of
wt (C57BL6/129), Trif
2/2, wt (C57BL/6) and Trif
Lps2/Lps2 mice on day seven after infection with CFT073 or DTcpC. (B) Bacterial numbers in urine of wt
and mutant mice after infection. (C) Kinetics of the MIP-2 response, measured in urine samples. (D) Neutrophil response kinetics in urine of wt and
mutant mice. P values (*p,0.05, **p,0.01 and ***p,0.001 for CFT073 versus DTcpC mutant and for wt versus mutant mice; Fisher’s exact test;
ns=not significant). (E) Abscess formation in mouse kidneys, seven days post-infection (Scale bar, 2 mm). (F) Abscess formation after CFT073 or
DTcpC infection, in percent of the total number of kidneys examined.
doi:10.1371/journal.ppat.1001120.g007
Figure 8. Inhibitory effects of the soluble TcpC TIR-domain on TLR signaling in murine macrophages. (A) Wt BMDM were stimulated
with Pam3Cys (1 mg/ml), poly(I:C) (2.5 mg/ml), ultrapure LPS from E. coli K12 (100 ng/ml), flagellin from S. typhimurium (1 mg/ml) and CpG 1826 (2 mM)
in the presence of titrated amounts of the purified TIR domain of TcpC (TIR-TcpC) as indicated. TNF secretion was analyzed 3 hr after stimulation.
(B) The experiment in (A) was repeated at the same time, side by side with Myd88
2/2 BMDM. Error bars represent SD from three individual cultures.
The experiment was repeated once with similar results.
doi:10.1371/journal.ppat.1001120.g008
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recruitment of IRAK-4, thus acting as a negative regulator of TLR
signaling [37]. SIGIRR, IRAK-M, SOCS1, Triad3A and SARM,
and the cytosolic domain of SIGIRR block TLR4 signaling
through TIR-TIR interactions preventing the recruitment of
IRAK and TRAF6 to MYD88. TcpC binds to TLR4 (unpub-
lished data) and MYD88 [12] through TIR domain interactions
and inhibits TLR4 and MYD88 dependent signaling in vivo, as well
as downstream effector functions. While many molecular interac-
tions remain to be defined, it is clear that this microbially induced
suppression of the host defense differs, in the classical sense, from
mucosal tolerance, which may be triggered by microbial or other
mucosal antigens, but is defined by the involvement of specific
immunity, with T cells as the main effector cells. In the case of
TcpC, the innate immune response is modified and the ‘‘tolerant’’
state appears to result from active microbial inhibition, rather than
from a lasting change in the immune status of the host, and from a
direct modification of host resistance rather than by inducing
tolerance. Further insights into these mechanisms may be helpful
to distinguish ‘‘bad’’ from ‘‘good’’ inflammation and to understand
how partial inhibition of MYD88, TRIF and TLR4 by TcpC
results in pathology while complete gene deletion is protective.
These findings also illustrate the importance of the host response
as a generator of pathology and suggest the possibility of
intervention to support ‘‘good’’ host responses, promoting
bacterial clearance and tissue integrity while inhibiting pathology.
Materials and Methods
Ethics statement







Lps2/Lps2 and C57BL6/129 Trif
2/2 mice were bred and housed
in the specific pathogen-free facilities of the MIG animal facilities
(Lund, Sweden) with free access to food and water. All
procedures were approved by the Animal Experimental Ethics
Committee at the Lund District Court, Sweden (numbers M166-
04 and M87-07), following Institutional, National, and European
Union guidelines.
Cell lines and reagents
The human epithelial cell line A498 (ATCC HTB44, human
kidney carcinoma, Manassas, VA, USA) was cultured in RPMI-
1640 supplemented with 1 mM sodium pyruvate, 1 mM non-
essential amino acids, gentamycin (50 mgm L
21) and 5% fetal calf
serum (PAA Laboratories, Pasching, Austria).
Alexa-fluor 568-goat anti-rabbit IgG and Alexa-fluor 488-goat
anti-rat were from Invitrogen (Eugen, Oregon, USA). Anti-rat
NIMP-R14 (ab2557) were from Abcam (Cambridge, UK) and
goat normal serum were from Dako (Denmark). The reagents
paraformaldehyde (Merck KGaA, Darmstadt, Germany), triton
X-100 (VWR International Ltd, England), isopentane (Sigma-
Aldrich, Germany), VECTASHIELD mounting medium (Vector
Laboratories, USA), poly-L-lysine-coated glass slides (Thermo
Scientific, Waltham, USA), DAPI (Invitrogen, Oregon, USA),
tryptic soy agar (Difco, Detroit, USA) and hematoxylin-eosin stain
(Histolab Products AB, Gothenburg, Sweden) were used. Mouse
MIP-2 quantification kit was from R&D systems (Abingdon, UK).
TargetAmp Nano-g Biotin-aRNA Labelling kit was from Epicen-
tre Biotechnologies (Madison, USA), RNeasy clean-up from
Qiagen (Alabama, USA) and the Procarta Human Cytokine 50-





2/2 [40] and Il-1b
2/2 [41]
mice were generated in the C57BL/6 genetic background and
Trif
2/2 [28] mice were generated in the C57BL6/129 genetic
background. Lps2, a non-functional codominant allele of Trif,
was induced by N-ethyl-N-nitrosourea mutagenesis on a pure
C57BL/6 mouse background [17] in the Scripps Institute animal
facilities (La Jolla CA). Il-1b
2/2 mice were provided by Max
Planck (Institute for Infection Biology, Berlin, Germany). Wild
type C57BL6/129 mice are the 50% backcross of C57BL/6





2/2) are backcross in 100% C57BL/6 wt mice and are pure.
Bacterial strains
E. coli CFT073 was isolated from the blood and urine of a
woman admitted to the University of Maryland Medical System
for treatment of acute pyelonephritis [42]. This hly1+, pap1+, sfa1+
and pil1+ strain expresses P fimbriae, hemolysin, and Type 1
fimbriae and is highly virulent in the CBA mouse model of
ascending UTI. It is cytotoxic for cultured human renal proximal
tubular epithelial cells [43]. CFT073 expresses the TcpC protein
and the ectcp sequences, which encode TcpC and were deleted in
the ectcp::kan mutant (DTcpC), as described [12]. The strains were
grown to stationary phase overnight on tryptic soy agar with
appropriate selection and suspended in 10 ml of phosphate-
buffered saline (PBS) (pH 7.2) to generate the bacterial suspension
used for inoculation (10
9 CFU, colony forming units/ml). The
bacteria were tested for virulence factor expression, including P
and Type 1 fimbriae [44].
Experimental UTI mice model







2/2 mice were used at 8–12
weeks of age. E. coli urinary tract infection was established as
described [45]. In brief, 0.1 ml of the bacterial suspension was
administered into the bladders of anesthetized mice (10
9 CFU/ml)
with the help of a soft polyethylene catheter (inner diameter
0.28 mm, outer diameter 0.61 mm;ClayAdams,NewJersey USA).
Prior to inoculation, urine samples were collected and cultured on
blood agar plates to ensure that the mice were uninfected. After
infection, urine was collected into sterile tubes through gentle
pressure on the mouse’s abdomen (5 h, 24 h and up to 6 days) and
neutrophils were quantified by light microscopy using a Burker
chamber. The urine samples and serial dilutions were quantitatively
cultured on tryptic soy agar (TSA) plates. Mice were sacrificed by
cervical dislocation while anesthetized. Bladders and kidneys were
removed under sterile conditions, placed into a plastic bag
containing 5 ml PBS (pH 7.2), homogenized in a Stomacher 80
homogenizer (Seward medical, London, UK) and plated on TSA
Figure 9. Effects of TcpC virulence in Il-1b
2/2 and Irf3
2/2 mice infected with CFT073 or DTcpC. (A) Bacterial burden (CFU) in kidneys of wt
(CF7BL/6), Il-1b
2/2 and Irf3
2/2 mice on day seven after infection with CFT073 or DTcpC. (B) Bacterial numbers in urine after infection. (C) Kinetics of
the MIP-2 response, measured in urine samples. (D) Neutrophil response kinetics in urine of wt and mutant mice. P values (**p,0.01 and ***p,0.001
for CFT073 versus DTcpC mutant and for wt versus mutant mice; Fisher’s exact test; ns=not significant). (E) Abscess formation in mouse kidneys,
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37uC overnight and visually scored for bacterial colonies. Kidneys
were also prepared for hematoxylin-eosin staining or immunohis-
tochemistry.
Histology and immunohistochemistry
Kidneys were fixed in freshly prepared 4% paraformaldehyde
soon after dissection and incubated overnight at 4uC. Further, the
fixed tissues were incubated in 15% sucrose (4uC/24 hr) and
washed in 25% ice cold sucrose (4uC/24 hr). Tissues were then
frozen in isopentane at 240uC and stored at 280uC for further
use. Cryostat sections were made with a steel knife (10 mm),
mounted onto poly-L-lysine-coated glass slides and stained.
The kidney sections from all mouse groups were stained for dual
immunohistochemistry as described [46]. Briefly, tissue sections
were dried at 37uC for 15 min, washed in PBS-0.2% Triton X-100
(pH 7.2) (2610 min/RT) and incubated (30 min/RT) with PBS-
0.2% Triton X-100+ 5% goat normal serum (Dako, Denmark).
Then the sections were incubated with primary anti-rat NIMP-
R14 (ab2557, Abcam, Cambridge, UK; 1:200) and antiserum to a
synthetic peptide within the PapG adhesin (1:200) for 2–3 hr at
RT. Negative controls consisted of only normal goat serum
(1:200). The kidney sections were washed in PBS (365 min) and
incubated (1 hr/RT) with secondary goat anti-rat immunoglob-
ulins (1:200), conjugated with Alexa 488 dye (A488; 495ext/519em
nm), and secondary goat anti-rabbit immunoglobulins (1:200),
conjugated with Alexa 568 dye (A568; 578ext/603em nm), as
fluorochrome (Invitrogen, USA). After washing in PBS (265 min),
specimens were counterstained (3 min/RT) with DAPI (0.05 mM)
for nuclei staining. Sections were washed again in PBS (10 min)
and mounted with VECTASHIELD mounting medium (Vector
Laboratories, USA) and kept in the dark. Sections were analyzed
by fluorescence microscopy (AX60, Olympus Opticals, Hamburg,
Germany) in the Department of Pathology, Lund University,
Sweden.
Cytokine measurements
Urine samples were collected at 0.6 hr and after 1, 2, 3, 4, and 6
days and stored at 220uC. MIP-2 in urine was quantified by
ELISA using the Mouse MIP-2 quantification kit (R&D systems,
Abingdon, UK) according to the manufacturer’s instructions and
urine was diluted five fold in sample buffer. The ELISA plates
were read at 450 nm in a Labsystems Multiskan PLUS reader
(Analytical Instruments LLC, Golden Valley, USA).
DNA microarray analysis
For the microarray study, 350,000 A498 cells were seeded in 6-
well plates and infected with CFT073 or DTcpC (10
8 CFU/ml) upon
confluency. Total RNA was extracted 4 hr after stimulation by acid
guanidinium thiocyanate-phenol-chloroform extraction (Trizol,
Invitrogen,USA) followed by a Qiagen RNeasy clean-up procedure.
RNA was reverse-transcribed to double stranded cDNA and
converted to biotin-labelled cRNA using a TargetAmp Nano-g
Biotin-aRNA Labelling kit (Epicentre Biotechnologies, Madison,
USA). Labelled cRNAs were hybridized onto an Illumina Human
WG6v3 Expression Beadchip for 16 hours at 58uC. The arrays were
then washed and stained based on the Illumina Wash Protocol and
then scanned using a BeadArray Scanner 500GX. The background
subtracted data were pre-processed to correct negative and non
significant intensities. Pre-processed data was normalized using the
cross correlation [47] and genes with a fold change of 2 were
identified as differentially expressed. Data was preprocessed using
RMA implemented in the free software packages R and Biocon-
ductor (http://www.r-project.org). In identification of CFT073 or
DTcpC-specificgenes,foldchangeof$2wasusedforthecomparison
CFT073 or DTcpC with its control and fold change of #1.5 was used
for the comparison DTcpC or CFT073 with its control, respectively.
In addition to the above fold change criteria, statistical t-test with
p#0.05 was further used in selection of differentially expressed genes
or CFT073/DTcpC specific genes. To further study signaling
pathways altered by TcpC, the differentially expressed genes were
analyzed using the Ingenuity Pathway Analysis software with default
settings (Ingenuity Systems, Redwood City, CA). In parallel, cDNA
was also quantified by RT-PCR using human primers IL-6
(Hs00174131_m1), IL-8 (Hs00174103_m1), NFKB1 (Hs00231653_
m1), cFOS (Hs01119266_g1), IRF3 (Hs01547283_m1), STAT1
(Hs01014002_m1), IRF7 (Hs00185375_m1) and TNF-a
(Hs01113624_g1) from Applied Biosystems.
Protein arrays
Kidney A498 cells were stimulated with CFT073 or DTcpC as
described above. Culture supernatants were collected and cleared
by centrifugation at 20,0006g before storage at 280uC. Cytokine
profile analysis was performed in triplicate using the Procarta
Human Cytokine 50-plex kit (Panomics, Fremont, USA) accord-
ing to manufacturer’s protocol. Cytokine levels were evaluated
using a Luminex 100 system (Luminex, Austin, TX, USA).
RT-PCR and ELISA of murine tubular kidney cells
Primary murine renal tubular epithelial cells (MRTEC) were
harvested from murine kidneys (C57BL/6, Trif
Lps2/Lps2,
Myd88
2/2) following microdissection and brief collagenase
digestion (2 mg/ml of Collagenase Type II). Cells were grown in
hormonally defined RPMI supplemented with epidermal growth
factor (Sigma, 50 pg/ml), insulin-transferrin-sodium selenite
media supplement (Gibco, diluted 1:100), Prostoglandin E1
(Sigma, 1.25 ng/ml), T3 (Sigma, 34 pg/ml), hydrocortisone
(Sigma, 18 ng/ml), 10% heat-inactivated FCS, and 0.5 mg/ml
gentamycin at 37uC. The cells were stimulated 5 days after the
primary explantation at 100% confluence and infected with
CFT073 or DTcpC (10
8 CFU/ml) for 4 hrs. Total extracted
mRNAs were converted to cDNA using RT2 First Strand Kit
(SABioscience Corporation, Fredrick, MA, USA). The mouse
primers used for RT-PCR GAPDH (QT01658692) and MIP-2
(QT00113253) were from Qiagen. Gene expression levels were
calculated by the DCt method and normalized to house-keeping
genes. cDNA was quantified by RT-PCR using a Rotor gene 2000
instrument (Corbett Life Science, Sydney, Australia) and normal-
ized against GAPDH for each gene. In parallel, MIP-2 in culture
supernatants was also quantified by ELISA using the Mouse MIP-
2 quantification kit (R&D systems, Abingdon, UK) according to
the manufacturer’s instructions.
BMDM and ligand stimulation assays
Wt or Myd88
2/2 BMDM (bone marrow derived macrophages)
were cultured in 6-well plates at a concentration of 0.5610
6/well
in DMEM supplemented with 10% FCS, 1% penicillin-strepto-
mycin and 0.1% 2-mercaptoethanol. Cells were stimulated with
the TLR ligands Pam3Cys, poly(I:C), LPS, flagellin or CpG-ODN
1826 in the absence or presence of titrated amounts of the purified
recombinant TIR domain of TcpC (TIR-TcpC) for 3 h. TNF was
quantified in the culture supernatant using ELISA Duo sets (R&D
Systems) as described by the manufacturer.
Statistical analysis
Bacterial counts and immune responses are presented as
geomean 6 SEM. Fisher’s exact test and two-tailed T test was
Escherichia coli TIR-Proteins
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Student’s t-test was used for protein array analysis. Wilcoxon’s
matched pairs test was used for paired comparisons. The level of
significance was set at p,0.05 for all tests.
List of ID numbers for genes and proteins of mouse and
humans
Gene ID number for human TLR4 is 7099, mouse Tlr4 is
21898, human MYD88 is 4615, mouse Myd88 is 17874, human
TRIF is 148022, mouse Trif is 106759, human IRF3 is 3661,
mouse Irf3 is 54131, human IL-1B is 3553 and mouse Il-1b is
16176.
Supporting Information
Figure S1 Response in murine tubular kidney cells infected with
CFT073 and DTcpC. MIP-2 response of murine tubular cells from
wt, Myd88
2/2 or Trif
Lps2/Lps2 mutant mice infected with CFT073
or DTcpC(Means 6 SEMs of three experiments). P values
(**p,0.01 for CFT073 versus DTcpC mutant and p,0.0001
comparing wt and Trif
Lps2/Lps2 versus Myd88
2/2 mutant cells.
Found at: doi:10.1371/journal.ppat.1001120.s001 (0.60 MB PDF)
Table S1 Comparison of gene expression levels in pathways
regulated by CFT073 and the DTcpC mutant. The Wilcoxon
matched pairs test was used to compare the effect of different types
of stimulation on different gene classes.
Found at: doi:10.1371/journal.ppat.1001120.s002 (0.11 MB PDF)
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